Dr. Randy Schatzman On Dodging Disruption: The New Fundraising Norm [...]

CMC Considerations For In-Human Studies with Drs. Edith Perez and [...]

Randy Schatzman, PhD, CEO of Bolt Biotherapeutics Biotech 2050 Podcast

[av_textblock size='' av-medium-font-size='' av-small-font-size='' av-mini-font-size='' font_color='' color='' av-desktop-hide='' av-medium-hide='' av-small-hide='' [...]